[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"shoulder-injuries\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:shoulder-injuries":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,17,0,[8,59,86,113,132,164,199,224,245,268,293,321,347,370,392,413,436],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":58},"100053446","phase-4-intravenous-dexamethasone-with-single-shot-versus-continuous-brachial-plexus-block-for-rebound-pain-after-shoulder-surgery-100053446",false,"NCT07699744","Intravenous Dexamethasone With Single-Shot Versus Continuous Brachial Plexus Block for Rebound Pain After Shoulder Surgery","Pain Management Protocol Optimization for Rebound Pain Prevention and Enhanced Recovery After Shoulder Surgery: A Randomized Noninferiority Trial of Intravenous Dexamethasone Combined With Single-Shot Versus Continuous Brachial Plexus Block","Inclusion Criteria:\n\n* Adult patients aged 19 to 79 years scheduled for elective shoulder surgery under brachial plexus block and monitored anesthesia care (MAC)\n\nExclusion Criteria:\n\n* Pre-existing neurological deficit of the brachial plexus\n* Emergency surgery\n* American Society of Anesthesiologists (ASA) physical status classification IV or higher\n* Contraindication or history of hypersensitivity to local anesthetics or dexamethasone\n* Severe pulmonary disease (e.g., chronic obstructive pulmonary disease)\n* Body mass index (BMI) ≥ 35 kg\u002Fm²\n* Long-term use of steroids\n* Long-term use of analgesics\n* Inability to cooperate or communicate\n* Pregnancy","ALL","19 Years","79 Years",{"count":20,"type":21},92,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","Shoulder surgery often causes severe pain after the operation. To control this pain, doctors commonly perform a nerve block (interscalene brachial plexus block), which numbs the shoulder area. However, when the effect of a single-injection nerve block wears off, many patients experience sudden, intense pain known as \"rebound pain\".\n\nOne way to prevent rebound pain is to place a thin catheter near the nerves so that local anesthetic can be given continuously for a longer period (continuous nerve block). However, this method is technically demanding and can cause problems such as catheter dislodgement, infection, and inconvenience for patients. Another simpler option is to give a single-injection nerve block together with an intravenous (IV) injection of dexamethasone, a steroid medication known to prolong the effect of nerve blocks and reduce rebound pain.\n\nThe purpose of this study is to determine whether a single-injection nerve block combined with IV dexamethasone (5 mg) is not inferior to a continuous nerve block in preventing rebound pain after shoulder surgery. A total of 92 adult patients scheduled for elective shoulder surgery will be randomly assigned to one of the two groups. The main outcome is the rebound pain score, defined as the difference between the last pain score recorded in the recovery room (while the nerve block is still working) and the highest pain score reported within the first 24 hours after the nerve block. The investigators expect that the simpler single-injection method with IV dexamethasone will provide comparable pain control while avoiding the complications and inconvenience of catheter-based continuous nerve blocks.",[27,28,29,30],"Pain, Postoperative","Rebound Pain","Shoulder Injuries","Rotator Cuff Injuries",[32,33,34,35,36,37,38,39,40,41,42,43,44,45],"Rebound pain","Interscalene brachial plexus block","Single-shot nerve block","Continuous peripheral nerve block","Perineural catheter","Dexamethasone","Intravenous dexamethasone","Shoulder surgery","Rotator cuff repair","Regional anesthesia","Postoperative analgesia","Multimodal analgesia","Non-inferiority trial","Enhanced recovery after surgery","NOT_YET_RECRUITING","2026-07-09",{"date":49,"type":50},"2026-07-13","ACTUAL",{"date":52,"type":21},"2026-07-15",{"date":54,"type":21},"2027-07-15",{"name":56,"class":57},"Seoul National University Hospital","OTHER",1,{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":4,"eligibilityCriteria":65,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":4,"enrollmentInfo":67,"targetDuration":4,"studyType":22,"phases":69,"briefSummary":71,"conditions":72,"keywords":73,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":58},"100506578","increased-home-based-physical-therapy-adherence-using-band-connects-virtuacare-platform-100506578","NCT05876208","Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform","Measuring the Effectiveness of BAND Connect's VirtuaCare™ Asynchronous Telerehabilitation Platform in Increasing Patient Adherence for Total Shoulder Arthroplasty and Rotator Cuff Repair Physical Therapy Rehabilitatio","Inclusion Criteria:\n\n* Dr. Brian Grawe will perform surgery, and participants will be undergoing post-operative physical therapy rehabilitation at UC Health.\n* Primary total shoulder arthroplasty and primary reverse total shoulder arthroplasty or Primary rotator cuff repair\n* Outpatient physical therapy prescribed by the doctor for post-operative rehabilitation\n\nExclusion Criteria:\n\n* Unplanned surgical procedure\n* Partial shoulder replacement or revision shoulder replacement\n* Revision rotator cuff repair\n* Fracture surgeries\n* Prior surgery within the last 5 years or less than 6 months between surgery on opposite shoulder\n* Length of stay in hospital greater than 3 days\n* Comorbidity: Uncontrolled diabetes patients; Diagnosed with cancer in the past 5 years or active disease; Any comorbidity that may impact compliance with the study protocol (completion of standard physical therapy rehabilitation procedures)\n* Injuries related to workers' compensation\n* Injuries involved in any pending litigation","18 Years",{"count":68,"type":21},60,[70],"NA","This study aims to enhance at-home therapy by introducing a new device called the BAND Connect's VirtuaCare™ platform. The study aims to determine whether patients can improve their adherence to at-home exercises using this device. Currently, research indicates that only 35% of patients undergoing physical therapy treatment fully comply with their prescribed plans of care, often neglecting their at-home exercises. To address this issue, a set of smart exercise tools called VirtuaCare™ has been developed. This platform provides patients with instructions on performing at-home exercises and offers real-time biofeedback to help them adjust their form if necessary. The study seeks to evaluate the effectiveness of BAND CVCP in assisting patients and improving their overall success with at-home therapy.",[29],[74,75],"Rotator Cuff Repair","Anatomic and Reverse Total Shoulder","RECRUITING","2026-04-28",{"date":79,"type":50},"2026-04-29",{"date":81,"type":50},"2022-07-05",{"date":83,"type":21},"2027-07-31",{"name":85,"class":57},"University of Cincinnati",{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":11,"sex":16,"minAge":93,"maxAge":4,"enrollmentInfo":94,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":97,"conditions":98,"keywords":4,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":58},"100625331","osseofit-stemless-shoulder-system-anatomic-100625331","NCT07421245","OsseoFit Stemless Shoulder System (Anatomic)","OsseoFit Stemless Shoulder System (Anatomic) Post-Market Clinical Follow-up Study","Inclusion Criteria:\n\n* Patient must be 20 years of age or older.\n* The patient must be anatomically and structurally suited, as evident by scapula and proximal humerus closure, to receive the implants.\n* Patient planned to receive OsseoFit™ anchor with uncemented fixation.\n* Patient planned to receive a Modular Alliance Glenoid with bone cement. The porous posts must be coated with Porous Plasma Spray (PPS) and may be inserted without bone cement.\n* Patient planned to receive shoulder arthroplasty due to osteoarthritis.\n* Patient must be able and willing to complete the protocol required follow-up schedule.\n* Patient must be able and willing to sign the IRB approved consent.\n\nExclusion Criteria:\n\n* Patient is unwilling or unable to give consent or to comply with the follow-up program.\n* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.\n* Patient is known to be pregnant or breastfeeding.\n* Patient is a vulnerable participant (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and\u002For anticipated to be non-compliant).\n* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.\n* Patient has any neuromuscular disease compromising the affected limb.\n* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site. This may include:\n\n  * Local\u002Fsystemic infection\n  * Sepsis\n  * Osteomyelitis\n* Patient presents with Osteomalacia.\n* Patient presents with a humeral bone fracture.\n* Patient presents with malunion or non-union of the tuberosities of the proximal humerus.\n* Patient has had a previous operative shoulder prosthesis (stem or stemless).\n* Patient has irreparable cuff tear.\n* Patient presents with inadequate humeral bone, which in the opinion of the Investigator, may lead to poor implant fixation. This may include but is not limited to:\n\n  * Osteoporosis\n  * Extensive Avascular Necrosis\n  * Rheumatoid Arthritis\n  * Metaphyseal bony defects (including large cysts)","20 Years",{"count":95,"type":21},136,"OBSERVATIONAL","The purpose of this clinical research protocol is to evaluate the safety, efficacy, and long-term outcomes of the OsseoFit Stemless Shoulder System (Anatomic) in patients with a primary diagnosis of osteoarthritis. The study aims to assess the intraoperative characteristics, postoperative complications, functional outcomes, and radiographic findings associated with the use of the stemless implant system. Ultimately, this research aims to improve patient outcomes, enhance surgical techniques, and inform clinical decision-making in the treatment of shoulder pathology.",[29,99,100,101,102],"Shoulder Pain","Shoulder Fractures","Shoulder Arthritis","Shoulder Disease","2026-04-22",{"date":105,"type":50},"2026-04-23",{"date":107,"type":21},"2026-04",{"date":109,"type":21},"2036-01",{"name":111,"class":112},"Zimmer Biomet","INDUSTRY",{"id":114,"slug":115,"hasResults":11,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":4,"eligibilityCriteria":119,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":120,"enrollmentInfo":121,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":123,"conditions":124,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":125,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":131},"100576701","mdr---comprehensive-primary-revision-stems-pmcf-100576701","NCT06788717","MDR - Comprehensive Primary Revision Stems PMCF","Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive® Primary Revision Stems (Implants and Instrumentation) - A Retrospective and Prospective Consecutive Series Study","Inclusion Criteria\n\n* Patient must be 18 years of age or older.\n* Patient must be willing and able to follow directions.\n* Study devices must have been implanted following the surgical technique and IFU for the Comprehensive Revision Stem\n\nExclusion Criteria\n\n* Off-label use.\n* Patient is a prisoner.\n* Patient is a current alcohol or drug abuser.\n* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.\n* Patient is unwilling to sign informed consent.\n* Uncooperative patient or patient with neurologic disorders who are incapable of following directions.","100 Years",{"count":122,"type":21},59,"The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.",[99,29,100,102,101],{"date":77,"type":50},{"date":127,"type":50},"2025-06-19",{"date":129,"type":21},"2040-12",{"name":111,"class":112},2,{"id":133,"slug":134,"hasResults":11,"nctId":135,"briefTitle":136,"officialTitle":137,"acronym":4,"eligibilityCriteria":138,"healthyVolunteers":11,"sex":16,"minAge":93,"maxAge":4,"enrollmentInfo":139,"targetDuration":4,"studyType":22,"phases":141,"briefSummary":142,"conditions":143,"keywords":146,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":158,"startDateStruct":159,"completionDateStruct":161,"leadSponsor":163,"locationsCount":5},"100438054","zimmer-biomet-shoulder-arthroplasty-pmcf-100438054","NCT04984291","Zimmer Biomet Shoulder Arthroplasty PMCF","Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study","Inclusion Criteria:\n\n* Patient must be 20 years of age or older.\n* Patient must be anatomically and structurally suited to receive shoulder arthroplasty implants.\n* Patient is a candidate for shoulder arthroplasty due to one or more of the following:\n\n  * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.\n  * Rheumatoid arthritis.\n  * Correction of functional deformity.\n  * Fractures of the proximal humerus, where other methods of treatment are deemed inadequate.\n  * Difficult clinical management problems, where other methods of treatment may not be suitable or may be inadequate.\n* Patient must be able and willing to complete the protocol required follow-up.\n* Patient must be able and willing to sign the IRB\u002FEC approved informed consent.\n* Patient has grossly deficient rotator, (for reverse application)\n\n  * With severe arthropathy and\u002For\n  * Previously failed shoulder joint replacement\n* Patient must have functional deltoid muscle (for reverse application)\n\nExclusion Criteria:\n\n* Patient is unwilling or unable to give consent or to comply with the follow-up program.\n* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.\n* Patient is known to be pregnant or breastfeeding.\n* Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and\u002For anticipated to be non-compliant).\n* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.\n* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site.\n* Patient has rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram.\n* Patient has any neuromuscular disease compromising the affected limb that would render the procedure unjustifiable.\n* Patient presents with osteoporosis, which in the opinion of the Investigator, may limit the subject's ability to support total shoulder arthroplasty using the study device.\n* Patient has osteomalacia.\n* Patient has a metabolic disorder that may impair bone formation.\n* Patient has deficient rotator cuff.\n* Patient presents with significant injury to the upper brachial plexus.\n* Patient has paralysis of the axillary nerve.\n* Patient has non-functional deltoid or external rotator muscles.",{"count":140,"type":21},584,[70],"The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.",[100,101,144,145,29,99],"Shoulder Osteoarthritis","Shoulder Deformity",[147,148,149,150,151,152,153,154,155,156,157],"Total Shoulder Arthroplasty","Glenoid","Humeral Stem","Stem Adapter","Humeral Head","Humeral Bearing","Humeral Trays","Head Adapter","Reverse","Anatomic","Hemi",{"date":77,"type":50},{"date":160,"type":50},"2021-07-28",{"date":162,"type":21},"2033-08-15",{"name":111,"class":112},{"id":165,"slug":166,"hasResults":11,"nctId":167,"briefTitle":168,"officialTitle":169,"acronym":4,"eligibilityCriteria":170,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":171,"enrollmentInfo":172,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":174,"conditions":175,"keywords":181,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":190,"lastUpdatePostDateStruct":191,"startDateStruct":193,"completionDateStruct":195,"leadSponsor":197,"locationsCount":4},"100633787","reliability-and-accuracy-of-a-new-clinical-test-for-biceps-lesions-100633787","NCT07531225","Reliability and Accuracy of a New Clinical Test for Biceps Lesions","Sensitivity and Specificity and Inter-Observer Reliability of a New Test for Lesion of the Long Head of the Biceps","Inclusion Criteria:\n\n* Patients aged 18-70 years presenting with shoulder pain suggestive of biceps pathology.\n* Healthy individuals matched to age, sex, and level of activities to serve as a control group (or the normal contralateral shoulder of the same patient).\n\nExclusion Criteria:\n\n* Patients who prefer conservative treatment.\n* Patients who have biceps belly (biceps fibers) tears.\n* Patients with an unstable shoulder because of the risk of dislocation during performing the new test.\n* Patients with a history of shoulder surgery within the past 6 months.\n* Patients with systemic inflammatory conditions affecting the joints (e.g., rheumatoid arthritis).\n* Patients unable to cooperate with physical examination.\n* Patients with contraindications to the gold standard diagnostic method (e.g., MRI contraindications).","70 Years",{"count":173,"type":21},144,"The purpose of this study is to evaluate the accuracy and reliability of a new physical examination test (referred to as Said's test) for diagnosing injuries to the biceps tendon in the shoulder, specifically lesions of the long head of the biceps and SLAP tears.\n\nDiagnosing biceps injuries during a physical exam can be challenging, and existing standard tests can vary in their accuracy. This study aims to determine if this newly developed physical test is a more sensitive, specific, and reliable tool for doctors to use in a clinical setting.\n\nThe study will enroll 144 adult participants (ages 18 to 70). These participants will be categorized into three groups: patients with isolated SLAP lesions, patients with complex shoulder injuries (such as a rotator cuff tear combined with a biceps lesion), and a control group of healthy individuals or asymptomatic shoulders.\n\nDuring the study, each participant will be examined by two independent doctors who are blinded to the patient's actual diagnosis. The doctors will perform the new physical test alongside traditional shoulder tests (the Speed's and O'Brien tests). To determine the true accuracy of these physical exams, the doctors' findings will be compared against definitive diagnostic methods, which will include an MRI, an MRA, or direct visualization during shoulder arthroscopy.\n\nBy comparing the physical exam results to the gold standard imaging or surgical findings, researchers will calculate the new test's sensitivity, specificity, and inter-observer reliability.",[176,177,178,179,29,180],"Lesion of Long Head of Biceps","SLAP Lesion","Biceps Tendinopathy","Rotator Cuff Tear","Biceps Instability",[182,183,184,185,186,187,188,189],"Said's Test","Speed's Test","O'Brien Test","Long Head of the Biceps","Bicipital Groove","Diagnostic Accuracy","Sensitivity and Specificity","Inter-observer Reliability","2026-04-09",{"date":192,"type":50},"2026-04-15",{"date":194,"type":21},"2026-05",{"date":196,"type":21},"2027-06",{"name":198,"class":57},"Assiut University",{"id":200,"slug":201,"hasResults":11,"nctId":202,"briefTitle":203,"officialTitle":203,"acronym":204,"eligibilityCriteria":205,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":4,"enrollmentInfo":206,"targetDuration":4,"studyType":22,"phases":208,"briefSummary":209,"conditions":210,"keywords":211,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":215,"lastUpdatePostDateStruct":216,"startDateStruct":218,"completionDateStruct":220,"leadSponsor":222,"locationsCount":131},"100517339","using-virtuacaretm-platform-for-home-programs-in-acute-and-chronic-shoulder-conditions-a-pilot-study-100517339","NCT06016257","Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study","VirtuaCare","Inclusion Criteria:\n\nPhysical therapy home program subjects\n\n* Subject 18 years or older\n* Outpatient physical therapy prescribed by doctor for shoulder rehabilitation.\n* No previous neurological condition\n* Understand English (exercises are only in English) Physical therapists\n* The therapists will be the ones who provide physical therapy treatment to the acute and chronic shoulder population.\n\nPatients who had usual and customary treatment for acute and chronic shoulder conditions\n\n• Any patient referred based on inclusion criteria noted above that are referred for outpatient physical therapy and had a previous acute or chronic shoulder condition, were 18 years and older and had no previously documented neurological condition.\n\nExclusion Criteria:\n\nPhysical therapy home program subjects\n\n* Prior surgery within the last 5 years or less than 6 months between surgery\n* Neurologic comorbidities that have functional deficits\n* Uncontrolled diabetes\n* Diagnosis with active cancer in the last two years\n* Unable to understand English\n\nPhysical therapists • Any therapist who does not provide physical therapy treatment for acute and chronic shoulder conditions.\n\nPatients who had usual and customary treatment for acute and chronic shoulder conditions\n\n• Any patient who had prior surgery within the last 5 years or less than 6 months between surgery, had neurological comorbidities that had documented functional deficits, documented uncontrollable diabetes, documented diagnosis of active cancer within the last two years.",{"count":207,"type":21},20,[70],"This study will be performed to determine if Band Connect's VirtuaCare™ platform increases patient compliance and provides an effective alternative to current physical therapy treatment while reducing the frequency of visits compared with standard orthopedic physical therapy treatment performed in the outpatient clinic.\n\nParticipants are being asked to take part in this research study if 18 years and older and have been prescribed physical therapy rehabilitation for an acute or chronic shoulder condition and as part of the participant's physical therapy will receive a shoulder exercise home program.",[102,29],[212,213,214],"Home program","Shoulder conditions","Adherence","2026-03-23",{"date":217,"type":50},"2026-03-27",{"date":219,"type":50},"2024-02-01",{"date":221,"type":21},"2026-12-31",{"name":223,"class":57},"Cedars-Sinai Medical Center",{"id":225,"slug":226,"hasResults":11,"nctId":227,"briefTitle":228,"officialTitle":229,"acronym":4,"eligibilityCriteria":230,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":4,"enrollmentInfo":231,"targetDuration":4,"studyType":22,"phases":233,"briefSummary":234,"conditions":235,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":236,"lastUpdatePostDateStruct":237,"startDateStruct":239,"completionDateStruct":241,"leadSponsor":243,"locationsCount":58},"100476725","subscapularis-repair-augmentation-for-total-shoulder-arthroplasty-100476725","NCT05487677","Subscapularis Repair Augmentation for Total Shoulder Arthroplasty","Augmentation of Subscapularis Repair in Total Shoulder Arthroplasty","Inclusion Criteria:\n\n* Total Shoulder Arthroplasty\n\nExclusion Criteria:\n\n* Vulnerable population",{"count":232,"type":21},100,[70],"The primary purpose of this research is to compare the images obtained by ultrasound between a standard repair of the subscapularis tissue and after repair with a Biobrace. The secondary purpose is to determine if there are any clinical differences.",[29],"2026-02-27",{"date":238,"type":50},"2026-03-03",{"date":240,"type":50},"2023-12-01",{"date":242,"type":21},"2028-12-01",{"name":244,"class":57},"Stanford University",{"id":246,"slug":247,"hasResults":11,"nctId":248,"briefTitle":249,"officialTitle":250,"acronym":4,"eligibilityCriteria":251,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":4,"enrollmentInfo":252,"targetDuration":4,"studyType":22,"phases":254,"briefSummary":255,"conditions":256,"keywords":258,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":260,"lastUpdatePostDateStruct":261,"startDateStruct":263,"completionDateStruct":265,"leadSponsor":267,"locationsCount":58},"100370921","pulsed-electromagnetic-field-pemf-therapy-for-post-operative-pain-following-orthopedic-surgery-100370921","NCT04109638","Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery","A Pilot Prospective, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy in Decreasing Post-Operative Pain Following Orthopedic Surgery","Inclusion Criteria:\n\n1. Subjects may be male or female greater or equal to 18 years of age (≥ 18) at the time of consent.\n2. Subjects who will be having shoulder or knee surgery are permitted.\n3. Subject must not have used NSAIDs for one (1) week prior to surgery.\n\n   a. a. Low-dose aspirin (81 mg) is permitted.\n4. Subject must be willing and able to participate in post-operative physical therapy exercises.\n5. Subject must understand and be willing to sign the IRB-approved Informed Consent Document.\n\nExclusion Criteria:\n\n1. Subject has a known collagen disorder such as, but not limited to, osteogenesis imperfecta (OI) or Ehlers-Danlos syndrome (EDS).\n2. Subject has a known inflammatory or autoimmune connective tissue disease such as, but not limited to, gout affecting the shoulder, scleroderma, SLE, rheumatoid disease, or calcific tendonitis of the shoulder.\n3. Subject has a metabolic bone disease such as Paget's disease or osteomalacia as documented in the medical record.\n4. Subject has a deltoid defect, deltoid palsy or any other pseudoparalysis.\n5. Subject is diabetic.\n6. Subject has HIV or hepatitis.\n7. Subject has a diagnosis of fibromyalgia or other chronic pain syndrome.\n8. Subject has shoulder or knee pain of unknown etiology.\n9. Subject has had an active malignancy in the past 5 years OR has an active or on-going neoplastic disease, except for benign skin cancer(s).\n10. Subject has undergone administration, within 30 days prior to surgery, of any type of corticosteroid (with the exception of asthma medications and ophthalmic medications), antineoplastic, immunostimulation or immunosuppressive agent.\n11. Subject is septic, or has a local or systemic infection.\n12. Subject has an admitted active substance abuse problem which includes recreational drugs and\u002For narcotics or a history of substance abuse where history is defined as \"not under the care of a physician\" for more than 5 years.\n\n    a. Prescriptive medical marijuana is not permitted, including CBD oils.\n13. Subject consumes more than 14 (men) or 7 (women) standard drinks (alcoholic units) per week where a drink equals a 12 oz. beer, or a 5 oz. glass of wine, or a 1.5 oz. shot of liquor.\n14. Subject is currently seeking or receiving worker's compensation for this injury or for an injury that has occurred more than 12 months prior to enrollment in this study or subjects who are currently in litigation or who have a history of litigation related to musculoskeletal diagnoses.\n15. Subject has major mental illnesses including major depression, bipolar disorder, schizophrenia or dementia that would prevent them from following the protocol and\u002For independently completing the patient reported outcomes measures.\n16. Subjects who have coexistent cervical spinal pathologies such as radiculopathies or myelopathies.\n17. Subject has a mental or physical condition that would prevent them from complying with the study protocol.",{"count":253,"type":21},76,[70],"The primary objective of this study is to prospectively determine, at 10 days after orthopedic shoulder or knee surgery, if pulsed electromagnetic field (PEMF) therapy is beneficial in reducing patient-reported post-operative pain, as measured by visual analog scale (VAS). The amount of pain medication taken daily and the physical function outcome scores after surgery and PEMF treatment will also be measured.",[257,29,27],"Knee Injuries",[259],"PEMF","2026-01-20",{"date":262,"type":50},"2026-01-21",{"date":264,"type":50},"2021-02-01",{"date":266,"type":21},"2027-02",{"name":244,"class":57},{"id":269,"slug":270,"hasResults":11,"nctId":271,"briefTitle":272,"officialTitle":273,"acronym":4,"eligibilityCriteria":274,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":275,"enrollmentInfo":276,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":278,"conditions":279,"keywords":280,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":284,"lastUpdatePostDateStruct":285,"startDateStruct":287,"completionDateStruct":289,"leadSponsor":291,"locationsCount":131},"100553426","kinesiophobia-scale-for-the-upper-extremity-100553426","NCT06485934","Kinesiophobia Scale for the Upper Extremity","Development of the Multidimensional Kinesiophobia Scale for the Upper Extremity: A Scale Development Study","Inclusion Criteria:\n\n* Tampa Kinesiophobia Score \\>37 points\n* Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity\n* Mini-Mental State Examination score \\>24 points\n\nExclusion Criteria:\n\n* Malignancy,\n* Psychiatric drug use,\n* Use of painkillers during evaluation periods,\n* Those who received physiotherapy before the study (last 6 months),\n* Those whose education level is below secondary school level,","65 Years",{"count":277,"type":21},150,"Questionnaires\u002Fscales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems.\n\nThe study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.",[29],[281,282,283],"Kinesiophobia","Shoulder","Development of Scale","2025-11-18",{"date":286,"type":50},"2025-11-19",{"date":288,"type":50},"2024-07-22",{"date":290,"type":21},"2026-06-01",{"name":292,"class":57},"Emre Şenocak",{"id":294,"slug":295,"hasResults":11,"nctId":296,"briefTitle":297,"officialTitle":297,"acronym":4,"eligibilityCriteria":298,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":299,"enrollmentInfo":300,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":301,"conditions":302,"keywords":307,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":312,"lastUpdatePostDateStruct":313,"startDateStruct":315,"completionDateStruct":317,"leadSponsor":319,"locationsCount":58},"100378588","evaluating-hemidiaphragmatic-paralysis-with-prolonged-neural-blockade-from-an-interscalene-brachial-plexus-block-100378588","NCT04209504","Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block","Inclusion Criteria:\n\n* English speaking 18-80 year old ASA 1-3 patients\n* Primary shoulder surgery\n* Must live within a 25 mile radius\n\nExclusion Criteria:\n\n* ASA 4 or 5\n* Revision shoulder surgery\n* Diagnosis of chronic pain\n* Daily chronic opioid use (over 3 months of continuous opioid use)\n* Inability to communicate pain scores or need for analgesia\n* Infection at the site of block placement\n* Age under 18 years old or greater than 80 years old\n* Pregnant women (as determined by point-of-care serum bHCG)\n* Intolerance\u002Fallergy to local anesthetics\n* Weight \\\u003C50 kg\n* BMI \\> 40\n* severe pulmonary disease including chronic obstructive pulmonary disease and restrictive lung disease\n* Suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years.\n* Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance.\n* Current or historical evidence of any clinically significant disease or condition that, in the opinion of the investigator, may increase the risk of surgery or complicate the subject's postoperative course.","80 Years",{"count":68,"type":21},"This prospective observational study aims to evaluate the incidence of hemidiaphragmatic paralysis in patients receiving interscalene brachial plexus nerve block with prolonged neural blockade. English speaking American Society of Anesthesiologists (ASA) 1-3 patients ages 18-80 receiving prolonged interscalene nerve block will be randomized into 3 groups: first group receiving a perineural catheter infusing 0.2% ropivacaine; the second group receiving a single shot injection of 10mL liposomal bupivacaine (Exparel; n=20) plus 5 mL 0.5% bupivacaine and the third receiving 20mL liposomal bupivacaine plus 5mL bupivacaine (to be determined by the attending anesthesiologist).Primary outcome will be incidence of hemidiaphragmatic paralysis postoperative day 1 as measured by point of care (POCUS) ultrasound.",[303,99,29,101,102,304,30,305,306,74],"Shoulder Surgery","Rotator Cuff Tears","Rotator Cuff Arthropathy of Left Shoulder","Rotator Cuff Arthropathy of Right Shoulder",[74,303,308,309,310,311],"Hemidiaphragmatic paralysis","Interscalene Block","Interscalene Catheter","Interscalene Liposomal Bupivacaine","2025-09-29",{"date":314,"type":50},"2025-10-01",{"date":316,"type":50},"2021-10-12",{"date":318,"type":21},"2026-08-31",{"name":320,"class":57},"Duke University",{"id":322,"slug":323,"hasResults":11,"nctId":324,"briefTitle":325,"officialTitle":326,"acronym":4,"eligibilityCriteria":327,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":328,"enrollmentInfo":329,"targetDuration":4,"studyType":22,"phases":331,"briefSummary":332,"conditions":333,"keywords":334,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":338,"lastUpdatePostDateStruct":339,"startDateStruct":341,"completionDateStruct":343,"leadSponsor":345,"locationsCount":131},"100582649","serratus-posterior-superior-intercostal-plane-block-for-arthroscopic-shoulder-surgery-100582649","NCT06866054","Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery","Evaluation of the Effectiveness of Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia Management in Patients Undergoing Arthroscopic Shoulder Surgery","Inclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) classification I-II\n* Scheduled for arthroscopic shoulder surgery under general anesthesia\n\nExclusion Criteria:\n\n* history of bleeding diathesis,\n* receiving anticoagulant treatment,\n* known local anesthetics and opioid allergy,\n* infection of the skin at the site of the needle puncture,\n* patients who do not accept the procedure","75 Years",{"count":330,"type":21},50,[70],"Postoperative pain is a significant problem in patients undergoing arthroscopic shoulder surgery. This situation disrupts the patient's comfort and affects the functional outcome after surgery by preventing early rehabilitation. Various methods are used for postoperative pain control. Intravenous opioid agents are one of the most commonly used analgesic techniques. However, opioids can cause undesirable side effects such as respiratory depression, sedation, constipation, allergic reactions, nausea, and vomiting. Therefore, alternative techniques are needed to reduce opioid use.\n\nSerratus posterior superior interfascial plane block (SPSIPB) is a novel interfascial plane block described by Tulgar et al in 2023. It is based on injection into the serratus posterior superior muscle at the level of the 2nd or 3rd rib. This block provides analgesia in cases such as interscapular pain, chronic myofascial pain syndromes, scapulocostal syndrome, and shoulder pain. It has been reported that SPSIPB provides effective shoulder analgesia.",[99,29],[335,336,337],"Arthroscopic Shoulder Surgery","Postoperative analgesia management","serratus posterior superior intercostal plane block","2025-07-01",{"date":340,"type":50},"2025-07-04",{"date":342,"type":50},"2025-04-10",{"date":344,"type":21},"2025-08-30",{"name":346,"class":57},"Kahramanmaras Sutcu Imam University",{"id":348,"slug":349,"hasResults":11,"nctId":350,"briefTitle":351,"officialTitle":352,"acronym":4,"eligibilityCriteria":353,"healthyVolunteers":354,"sex":16,"minAge":66,"maxAge":355,"enrollmentInfo":356,"targetDuration":4,"studyType":22,"phases":358,"briefSummary":359,"conditions":360,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":361,"lastUpdatePostDateStruct":362,"startDateStruct":364,"completionDateStruct":366,"leadSponsor":368,"locationsCount":58},"100465759","subscap-reverse-shoulder-arthroplasty-100465759","NCT05344898","Subscap Reverse Shoulder Arthroplasty","Subscapularis Repair in Reverse Shoulder Arthroplasty: A Multi-Center Randomized Single Blinded Superiority Study","Inclusion Criteria:\n\n1. 18 to 95 years old\n2. Undergoing reverse shoulder arthroplasty for any indication including revision surgery\n\nExclusion Criteria:\n\n1. Irreparable Subscapularis Tendon\n\n   a. Reparability of Subscapularis will be determined based on MRI or CT scan obtained preoperatively and confirmed intraoperatively. Tendons must be intact with less than Grade I or II Fatty Infiltration as determined by the Goutallier classification.\n2. Any history of proximal humerus fracture\n3. Any revision with proximal humerus bone loss",true,"95 Years",{"count":357,"type":21},118,[70],"The subscapularis is part of the rotator cuff and is release as part of a reverse shoulder replacement. The decision to repair this tendon is controversial. This research is being done to help determine if rotator cuff repair improves or hinders shoulder replacement. A worrisome but rare complication after shoulder replacement is dislocation. Rotator cuff repair may help reduce this risk. The repair may hinder some of the range of motion afterwards or could help with internal rotation strength. There is a chance that the repair doesn't matter at all. The goal of this study is to delineate outcomes after reverse shoulder arthroplasty with the respect to management of the subscapularis tendon. Further information about rotator cuff repair after reverse shoulder replacement can help define complications, potentially decrease OR time, and improve functional outcomes. A total of 148 patients will be enrolled and the duration of the study will be 5 years. All patients will be required to follow-up at 2¬-week, 6-week, 3-month, 6-month, 1-year, and 2-year post-operative marks. Any time information is collected for a study there is a small risk of breach of confidentiality. There are no monetary costs or payments associated with this study. You may or may not benefit by taking part in this study. There is no guarantee that you will receive direct benefit from your participation in this study. To be clear, participation in this study is completely voluntary.",[29,30],"2025-06-18",{"date":363,"type":50},"2025-06-25",{"date":365,"type":50},"2022-11-15",{"date":367,"type":21},"2027-05-15",{"name":369,"class":57},"University of Maryland, Baltimore",{"id":371,"slug":372,"hasResults":11,"nctId":373,"briefTitle":374,"officialTitle":375,"acronym":4,"eligibilityCriteria":376,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":4,"enrollmentInfo":377,"targetDuration":4,"studyType":96,"phases":4,"briefSummary":379,"conditions":380,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":382,"lastUpdatePostDateStruct":383,"startDateStruct":385,"completionDateStruct":387,"leadSponsor":389,"locationsCount":391},"100540752","sportspro-post-market-clinical-follow-up-study-100540752","NCT06320925","SportsPro: Post-Market Clinical Follow Up Study","A Retrospective, Multi-Center, Post-Market Clinical Follow-Up Study of Stryker Class IIb Implants","Inclusion Criteria:\n\n1. Subject was ≥ 18 years of age at the time of the surgery\n2. Subject has undergone joint space repair using one of the study devices\n\nExclusion Criteria:\n\n1. Subjects who are less than 6 months post-intervention\n2. Concurrent participation in an investigational clinical study during the study period",{"count":378,"type":21},1500,"Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)",[29,257,381],"Hip Injuries","2025-05-22",{"date":384,"type":50},"2025-05-29",{"date":386,"type":50},"2023-12-05",{"date":388,"type":21},"2026-12-01",{"name":390,"class":112},"Stryker Endoscopy",3,{"id":393,"slug":394,"hasResults":11,"nctId":395,"briefTitle":396,"officialTitle":397,"acronym":4,"eligibilityCriteria":398,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":4,"enrollmentInfo":399,"targetDuration":4,"studyType":22,"phases":400,"briefSummary":401,"conditions":402,"keywords":4,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":404,"lastUpdatePostDateStruct":405,"startDateStruct":407,"completionDateStruct":409,"leadSponsor":411,"locationsCount":4},"100564172","analysis-of-sleep--recovery-following-rotator-cuff-repair-surgery-100564172","NCT06625723","Analysis of Sleep & Recovery Following Rotator Cuff Repair Surgery","Investigating the Impact of a Sleep Aid on Sleep and Recovery Following Rotator Cuff Repair Surgery","Inclusion Criteria:\n\n* Rotator Cuff Tear\n\nExclusion Criteria:\n\n* Prior ipsilateral shoulder surgery\n* Ipsilateral upper extremity neurological deficit",{"count":68,"type":21},[70],"Postoperative recovery following a rotator cuff repair surgery can be challenging. In particular, sleeping is difficult given the restrictions of the operative shoulder. This study aims to evaluate a postoperative sleep device that will allow for safe and comfortable positioning of the arm, with the anticipated effect to improve postoperative recovery and sleep.",[304,30,99,29,403],"Shoulder Impingement","2024-11-14",{"date":406,"type":50},"2024-11-18",{"date":408,"type":21},"2024-12-01",{"date":410,"type":21},"2027-04-01",{"name":412,"class":57},"New York Presbyterian Hospital",{"id":414,"slug":415,"hasResults":11,"nctId":416,"briefTitle":417,"officialTitle":417,"acronym":418,"eligibilityCriteria":419,"healthyVolunteers":354,"sex":16,"minAge":66,"maxAge":420,"enrollmentInfo":421,"targetDuration":4,"studyType":22,"phases":423,"briefSummary":424,"conditions":425,"keywords":4,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":427,"lastUpdatePostDateStruct":428,"startDateStruct":430,"completionDateStruct":432,"leadSponsor":434,"locationsCount":58},"100562403","ability-of-rotator-cuff-muscle-strength-levels-assessed-by-isokinetic-dynamometry-to-predict-return-to-sport-after-shoulder-stabilization-surgery-by-open-latarjet-procedure-100562403","NCT06602713","Ability of Rotator Cuff Muscle Strength Levels, Assessed by Isokinetic Dynamometry, to Predict Return to Sport After Shoulder Stabilization Surgery by Open Latarjet Procedure","ISO-LAT","Inclusion Criteria:\n\nPatient group:\n\n* Be aged between 18 and 45\n* Occurrence of the injury during the practice of a sporting activity\n* Post-traumatic anterior glenohumeral subluxation\u002Fdislocation\n* Contralateral shoulder with no history of injury\n* No other associated shoulder pathology\n* Patient scheduled for shoulder stabilizing surgery using an open Latarjet procedure performed by one of the surgeons at the Santy Orthopedic Center (Lyon)\n* No contraindication to isokinetic assessment\n* Patient having signed informed consent\n* Subject affiliated or beneficiary of a social security scheme\n\nHealthy volunteers:\n\n* Be aged between 18 and 45\n* Regularly practice a sporting activity\n* No contraindication to isokinetic assessment\n* Person having signed informed consent\n* Subject affiliated or beneficiary of a social security scheme\n\nExclusion Criteria:\n\nPatient group:\n\n* Contraindication from the sports clinician or surgeon\n* Have another pathology in the upper limbs.\n* Have constitutional hyperlaxity\n* Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision\n\nHealthy volunteer group (athletes without a history of shoulder pathology):\n\n* Declare a history of pain\u002Finjury in the upper limbs in the last 6 months\n* Declare a history of orthopedic surgery in the upper limbs\n* Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision","45 Years",{"count":422,"type":21},210,[70],"The stabilization surgical treatment by open Latarjet procedure is one of the reference treatments after anterior glenohumeral dislocation in athletes. This surgical technique allows low recurrence rates and high return to sport rates. Indeed, more than 90% of athletes return to sport after this type of surgery, but only 60% are able to resume the same activity as a preinjury level of performance. Therefore, adaptations in the postoperative management of athletes patients seem necessary. Isokinetic dynamometry is considered the gold standard to provide an objective assessment of muscle strength abilities, particularly in the clinical setting. Although rehabilitation exercises are prescribed early after the Latarjet procedure, muscle deconditioning occurs during the postoperative phase, limiting the abilities of the rotator cuff muscles to provide stability to the glenohumeral joint. Therefore, recovery of all components of strength, i.e. maximal strength, power, and strength endurance of the rotator cuff muscles appears crucial for the athletes to return to their sport at the pre-injury level. However, at present, the strength levels to be recovered remain to be defined.",[426,29,30],"Latarjet","2024-09-17",{"date":429,"type":50},"2024-09-19",{"date":431,"type":21},"2024-10-01",{"date":433,"type":21},"2028-10-01",{"name":435,"class":57},"Ramsay Générale de Santé",{"id":437,"slug":438,"hasResults":11,"nctId":439,"briefTitle":440,"officialTitle":440,"acronym":441,"eligibilityCriteria":442,"healthyVolunteers":11,"sex":16,"minAge":66,"maxAge":275,"enrollmentInfo":443,"targetDuration":4,"studyType":22,"phases":445,"briefSummary":446,"conditions":447,"keywords":448,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":453,"lastUpdatePostDateStruct":454,"startDateStruct":456,"completionDateStruct":458,"leadSponsor":460,"locationsCount":58},"100557284","efficacy-of-a-criteria-based-clinical-pathway-for-rehabilitation-of-shoulder-injuries-100557284","NCT06536114","Efficacy of a Criteria Based Clinical Pathway for Rehabilitation of Shoulder Injuries","CRISP","Inclusion Criteria:\n\n* Active-duty Service members over the age of 18 who are seeking medical attention for shoulder pain or injury will be recruited to participate in this study.\n\nExclusion Criteria:\n\n* The exclusion criteria include individuals who have sustained cervical or thoracic spine injury in the past year; an upper extremity or spine injury within the past year and have not been cleared to perform their previous duty requirements; a diagnosis of adhesive capsulitis; individuals referred to post-operative rehabilitation for the shoulder; individuals who are scheduled for shoulder surgery within the following 12 weeks; pain originating from a body region other than shoulder or is non-orthopaedic in nature; individuals who have sustained an upper extremity limb loss; individuals pending a medical evaluation board, discharge from the military, or pending litigation for an injury.",{"count":444,"type":21},250,[70],"The goal of this clinical trial is to compare the current standard of care for rehabilitation of non-operative shoulder injuries to a novel, criteria-based approach (CRISP). Additionally, this study will identify factors which contribute to return to duty readiness. The main questions it aims to answer are:\n\n* Are there differences in patient reported outcomes between participants who undergo the criteria-based rehabilitation program versus the standard of care for shoulder injuries?\n* Are there differences in clinical measures (strength, etc.) between participants who undergo the criteria-based rehabilitation program versus the standard of care for shoulder injuries?\n* Are there clinical or rehabilitation factors, or participant characteristics, that contribute to return to duty readiness?\n\nParticipants will be randomized to either complete their rehabilitation per the standard of care with a physical therapist in a Military Treatment Facility or complete the CRISP program with a research physical therapist. Participants will:\n\n* Attend physical therapy for a non-operative shoulder injury\n* Attend initial and final clinical assessments at the clinic\n* Complete patient reported outcomes at 1-, 3-, 6- and 12-month timepoints",[99,29],[449,450,451,452],"shoulder","return-to-duty","physical therapy","rehabilitation","2024-07-31",{"date":455,"type":50},"2024-08-02",{"date":457,"type":21},"2025-03-01",{"date":459,"type":21},"2027-08-30",{"name":461,"class":462},"United States Naval Medical Center, San Diego","FED"]